49 results
6-K
EX-99.1
GNFT
Genfit
20 Sep 23
Current report (foreign)
4:44pm
, and may continue to experience delays and challenges in enrollment in clinical trials due to the COVID-19 pandemic, for example with patients postponing
6-K
EX-99.1
GNFT
Genfit
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
with the COVID pandemic. Topline data are expected in the next few months.
GENFIT then strengthened, diversified and expanded our Research and Development … of its drug and diagnostic candidates, the impact of the COVID-19 pandemic, exchange rate fluctuations, potential synergies related to the acquisition
6-K
EX-99.1
GNFT
Genfit
10 Nov 22
GENFIT Reports Third Quarter 2022 Financial Information
4:10pm
candidates, the impact of the COVID-19 pandemic, exchange rate fluctuations and the Company’s continued ability to raise capital to fund its development
6-K
EX-99.1
vni7oiaypzl9
25 Oct 22
Current report (foreign)
4:10pm
6-K
EX-99.1
680yaq44up
29 Sep 22
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
4:10pm
6-K
EX-99.1
culvx7fykss
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.2
jlb1q wk9yvum7hu2
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.1
49hknb5s1w6tp9sk35t3
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
EX-99.1
25xgc
13 Sep 22
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
4:15pm
6-K
EX-99.1
jjqh653sa39dx
7 Apr 22
GENFIT Reports Full-Year 2021 Financial Results and Provides Corporate Update
4:10pm
6-K
EX-99.1
94wrqu6q
1 Mar 22
Current report (foreign)
6:08am
6-K
EX-99.1
ax6cvs
17 Dec 21
On heels of global strategic partnership announced today, GENFIT acquires rights to novel asset
6:05am
6-K
EX-99.1
pdfx7dktkquck
18 Nov 21
Current report (foreign)
4:20pm
6-K
EX-99.1
x7msrgfp
9 Nov 21
GENFIT Announces First Patient First Visit for the Evaluation of NTZ in Subjects with Hepatic Impairment as part of its ACLF Program
4:15pm
6-K
EX-99.1
shkj5w
8 Nov 21
Current report (foreign)
4:15pm
6-K
EX-99.1
go7jk0
2 Nov 21
Current report (foreign)
5:15pm